Promising Phase 2 Results for Zanidatamab in HER2+ Biliary Tract Cancer: ASCO 2024 Update ASCO Annual Meeting 2 Mins Read283 Author: Dr. Shubham Pant, MD – MD Anderson Overview: At the ASCO 2024 conference, Dr. Shubham Pant, MD – MD…
